Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Cellular Biomedicine Group Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

21 Feb 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - CELLULAR BIOMEDICINE GROUP INC (CBMG-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

26 Feb 2015 Thomson Reuters Stock Report 11 $25.00

ValuEngine Industry Report for Medical-biomed/genetics(CBMG)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

25 Feb 2015 ValuEngine, Inc. 10 $49.00

"The Economy Matters" Report for CBMG: the economy's impact on CBMG's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

24 Feb 2015 MacroRisk Analytics/EconomicInvestor 8 $25.00

CELLULAR BIOMEDICAL GROUP INC (CBMG) - REPORT FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

21 Feb 2015 Pechala's Reports 1 $25.00

Cellular Biomedicine Group Inc.: CBMG Acquires Rights to Four CAR T-Cell Targets

The following is an excerpt from the Streetwise Reports interview with Stephen Dunn, analyst with LifeTech Capital, "Immuno-O...

19 Feb 2015 Streetwise Reports 2 $12.00

Immuno-Oncology Promises Continued Wealth and Health: LifeTech Capital's Stephen Dunn

Immuno-oncology—disabling cancer's defenses so that a patient's own immune system can seek it out and destroy it—took center ...

19 Feb 2015 Streetwise Reports 6 $46.00

TheStreet.com Ratings Stock Report For: CELLULAR BIOMEDICINE GROUP (CBMG)

15 Feb 2015 TheStreet.com Ratings 5 $10.00

TheStreet.com Ratings Stock Report For: CELLULAR BIOMEDICINE GROUP (CBMG)

08 Feb 2015 TheStreet.com Ratings 5 $10.00

Wright Investors Service Comprehensive Report for Cellular Biomedicine Group Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

03 Feb 2015 Wright Reports 56 $75.00